MANGALAMNSEMangalam Drugs And Organics Limited· PharmaceuticalsHighNegative
Announced Fri, 17 Apr · 13:08 IST

Mangalam Drugs And Organics Limited has informed the Exchange regarding Resignation of Ms. Anuradha Pandey as Company Secretary & Compliance Officer of the company w.e.f. March 29, 2026.

Kmp ResignedManagement Changes View source PDF

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹29.74
prior close
₹29.55
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.2+0.2+0.2-1.5-3.4-5.2-4.8-6.6-4.7+4.0+2.2+0.9-6.8
Up moveDown movePending
AI summary

Ms. Anuradha Pandey has resigned from the position of Company Secretary & Compliance Officer of Mangalam Drugs And Organics Limited. Her resignation letter was dated January 2, 2026, and her last working day was March 29, 2026. The reason given is that she is moving on to pursue career opportunities outside the company. The disclosure was filed late (on April 17, 2026) due to an administrative oversight in tracking the 7-day filing deadline, and the company has now submitted a revised disclosure along with her resignation letter and detailed reasons as required under SEBI LODR Regulations.

Likely market impact

The Company Secretary is a Key Managerial Personnel, so the role needs to be filled promptly to ensure compliance and smooth governance. This is a routine exit and unlikely to materially impact the stock, but the late filing of the disclosure is a minor governance red flag that investors should note.